Biological Markers of Response to Treatment in Major Depressive Disorder
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if two tests are useful in predicting whether
someone with depression will get better when he or she is treated with an FDA approved
antidepressant medication (either citalopram or escitalopram).